Reprieve Cardiovascular Revenue and Competitors
Estimated Revenue & Valuation
- Reprieve Cardiovascular's estimated annual revenue is currently $5M per year.
- Reprieve Cardiovascular's estimated revenue per employee is $251,000
Employee Data
- Reprieve Cardiovascular has 20 Employees.
- Reprieve Cardiovascular grew their employee count by 0% last year.
Reprieve Cardiovascular's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP, Clinical & Regulatory Affairs | Reveal Email/Phone |
3 | VP R&D | Reveal Email/Phone |
4 | VP Strategy and Innovation | Reveal Email/Phone |
5 | Managing Director and Chief Financial Officer | Reveal Email/Phone |
6 | Director Operations | Reveal Email/Phone |
7 | Field Clinical Director | Reveal Email/Phone |
8 | Director Quality | Reveal Email/Phone |
9 | Chief Operating Officer | Reveal Email/Phone |
10 | Director Clinical Affairs | Reveal Email/Phone |
Reprieve Cardiovascular Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $9.8M | 39 | 3% | N/A | N/A |
#2 | $8.5M | 34 | 3% | N/A | N/A |
#3 | $3M | 12 | -29% | N/A | N/A |
#4 | $5630M | 7477 | -11% | $450M | N/A |
#5 | $4.5M | 18 | 6% | N/A | N/A |
#6 | $7.2M | 57 | 27% | $29.6M | N/A |
#7 | $14.3M | 57 | -12% | N/A | N/A |
#8 | $2.3M | 18 | 6% | $44M | N/A |
#9 | $40.7M | 162 | -1% | N/A | N/A |
#10 | $45.7M | 182 | -5% | N/A | N/A |
What Is Reprieve Cardiovascular?
Reprieve Cardiovascular is a pioneering medical device company focused on improving outcomes for patients suffering from acute decompensated heart failure (ADHF). The company's Reprieve technology is being investigated as an innovative fluid management therapy. Providing clinicians with the ability to precisely control a patient's fluid volume may both enable improved cardiac care, as well as, be instrumental in the decongestion of ADHF patients. Reprieve Cardiovascular is led by a seasoned management team with extensive experience in the medical device industry.
keywords:N/A
N/A
Total Funding
20
Number of Employees
$5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Reprieve Cardiovascular News
The main aim of the REPRIEVE trial is to assess the effect of a cholesterol-lowering statin medication on cardiovascular disease outcomes...
A reliable, individualized, and dynamic surrogate of cardiovascular risk, ... Reprieve Cardiovascular, 3ive, Renalytix, and Vifor in the past 3 years.
Other Companies in Milford
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2M | 20 | N/A | N/A |
#2 | $2.1M | 21 | 11% | N/A |
#3 | $5.2M | 21 | -38% | N/A |
#4 | $3M | 21 | 0% | N/A |
#5 | $2.9M | 23 | -23% | N/A |